Results from AGILE: ivosidenib-azacitidine vs azacitidine-placebo in patients with IDH1m AML
4 months ago
[{"url":"https://i.ytimg.com/vi/4kae6Ain6f0/hq720.jpg?sqp=-oaymwEcCOgCEMoBSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLBYjBOb95UmoDh8RJEQAtDIkMk41A","width":360,"height":202},{"url":"https://i.ytimg.com/vi/4kae6Ain6f0/hq720.jpg?sqp=-oaymwEcCNAFEJQDSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLCElThZ1YgsM8uGzNu9dRVU1nFs1A","width":720,"height":404}]
{"url":"https://i.ytimg.com/an_webp/4kae6Ain6f0/mqdefault_6s.webp?du=3000&sqp=CITksKkG&rs=AOn4CLAcTykdY50ugWuuf3N2PTW5DHpqKg","width":320,"height":180}
[{"text":"Vidhya Murthy, MBBS, MRCP, FRCPath, FRCP, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK,\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"Results from AGILE: ivosidenib-azacitidine vs azacitidine-placebo in patients with IDH1m AML by VJHemOnc \u2013 Video Journal of Hematological Oncology 64 views 4 months ago 5 minutes, 2 seconds","duration":"5 minutes, 2 seconds"}